Table 3.
Treatment | Arterial Blood Gas |
Venous Blood Gas |
||||||||
---|---|---|---|---|---|---|---|---|---|---|
Time (FiO2) |
||||||||||
30 (0.21) | 90 (0.21) | 150 (0.10) | 210 (0.10) | 240 (0.21) | 30 (0.21) | 90 (0.21) | 150 (0.10) | 210 (0.10) | 240 (0.21) | |
pH | % change from baseline | pH | % change from baseline | |||||||
VEH | 7.45 ± 0.02 | −0.35 ± 0.32 | −1.05 ± 1.28 | −1.43 ± 0.71 | −1.06 ± 1.15 | 7.42 ± 0.02 | −0.44 ± 0.47 | −0.56 ± 0.69 | −1.15 ± 0.78 | −0.11 ± 0.00 |
5-HMF-20 | 7.42 ± 0.04 | 0.10 ± 0.30∗ | −0.18 ± 0.74 | −0.98 ± 1.40 | −1.36 ± 1.24‡ | 7.38 ± 0.04 | −0.15 ± 0.37 | −0.98 ± 1.74 | −0.92 ± 1.90 | −1.23 ± 1.74 |
5-HMF-40 | 7.44 ± 0.04 | −0.01 ± 0.45 | −0.92 ± 1.06 | −1.12 ± 1.32 | −2.29 ± 1.07‡ | 7.4 ± 0.03 | −0.13 ± 0.11 | −0.81 ± 0.91 | −1.29 ± 0.77‡ | −1.79 ± 0.15‡ |
pCO2 (mmHg) | % change from baseline | pCO2 (mmHg) | % change from baseline | |||||||
VEH | 43.53 ± 3.56 | −0.96 ± 6.54 | −39.49 ± 8.99‡ | −40.16 ± 11.51‡ | −36.53 ± 3.94‡ | 48.6 ± 3.95 | 3.31 ± 12.50 | −30.05 ± 9.72‡ | −30.25 ± 4.50 | −33.77 ± 0.00‡ |
5-HMF-20 | 43.76 ± 3.31 | −5.13 ± 6.01 | −33.6 ± 6.44‡ | −43.55 ± 7.53‡ | −38.65 ± 8.65‡ | 52.05 ± 1.93 | −3.72 ± 3.49 | −34.99 ± 2.77‡ | −43.05 ± 4.77∗‡ | −40.73 ± 10.76‡ |
5-HMF-40 | 43.8 ± 2.66 | −7.58 ± 5.47 | −35.31 ± 6.85‡ | −36.84 ± 6.32‡ | −34.52 ± 16.15‡ | 49.8 ± 2.86 | −4.82 ± 5.81 | −29.24 ± 8.38‡ | −39.23 ± 4.86‡ | −47.92 ± 24.87‡ |
pO2 (mmHg) | % change from baseline | pO2 (mmHg) | % change from baseline | |||||||
VEH | 85.78 ± 10.34 | −8.58 ± 7.82 | −69.03 ± 2.8‡ | −64.69 ± 2.30‡ | −26.02 ± 35.03 | 41.8 ± 3.37 | −7.66 ± 7.39 | −53.6 ± 21.28‡ | −54.41 ± 7.99‡ | −29.36 ± 0.00 |
5-HMF-20 | 83.53 ± 10.46 | −1.92 ± 13.91 | −65.49 ± 3.79‡ | −59.14 ± 9.04‡ | 7.64 ± 10.66∗ | 41 ± 3.62 | −13.29 ± 5.39 | −56.63 ± 7.64‡ | −51.85 ± 11.91‡ | −5.96 ± 22.70 |
5-HMF-40 | 95.9 ± 25.95 | −13.11 ± 14.53 | −69.85 ± 7.28‡ | −72.88 ± 5.91&‡ | −20.99 ± 15.39& | 40.07 ± 4.23 | −7.48 ± 5.57 | −62.45 ± 5.99‡ | −58.71 ± 6.20‡ | 24.89 ± 7.74 |
SO2 (mmHg) | % change from baseline | SO2 (mmHg) | % change from baseline | |||||||
VEH | 96.17 ± 3.62 | −2.68 ± 4.44 | −59.6 ± 8.57‡ | −51.33 ± 3.12‡ | −13.15 ± 21.89 | 67.4 ± 4.33 | −11.78 ± 9.40 | −68.94 ± 18.86‡ | −74.09 ± 6.51‡ | −39.86 ± 0.00 |
5-HMF-20 | 95.37 ± 2.21 | −0.43 ± 3.18 | −52.92 ± 8.61‡ | −49.87 ± 14.28‡ | 0.45 ± 2.21 | 64.42 ± 6.49 | −14.99 ± 6.71 | −73.53 ± 4.21‡ | −70.91 ± 7.84‡ | −2.71 ± 16.62 |
5-HMF-40 | 96.23 ± 1.8 | −1.36 ± 1.57 | −61.04 ± 5.87‡ | −64.7 ± 4.60‡ | −6.32 ± 7.17 | 63.34 ± 5.77 | −11.02 ± 6.83 | −80.32 ± 2.71‡ | −78.16 ± 6.17‡ | 10.17 ± 7.42‡ |
Groups: VEH (100 ml NS), 5-HMF-20 (20 mg/kg 5HMF dissolved in 100 ml NS) and 5-HMF-40 (40 mg/kg 5HMF dissolved in 100 ml NS). FiO2, FiO2, Fraction of Inspired Oxygen. Baseline absolute values in column with gray background and percentage change from baseline in remaining columns ± SD. ∗ vs. VEH (p ≤ 0.05); # vs. VEH (p ≤ 0.01); & vs. 20 mg/kg 5-HMF (p ≤ 0.05); ‡ vs. baseline (p ≤ 0.05).